Richard Johnson, President and CEO of the Parenteral Drug Association (PDA) speaks with Biopharm International.
Richard Johnson, President and CEO of the Parenteral Drug Association (PDA) spoke with BioPharm International about drug shortages, manufacturing challenges, and industry issues.
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.